Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Imitola

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Journal of Neuroimmunology|April 27, 2019
Regenerative neuroimmunology: The impact of immune and neural stem cell interactions for translation in neurodegeneration and repairJaime Imitola
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2019
New age for progressive multiple sclerosisJaime Imitola
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Prospects for neural stem cell-based therapies for neurological diseasesJaime Imitola
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2022
All anti-CD20 monoclonal antibodies have similar efficacy and risks: CommentaryIan Dimaandal, Jaime Imitola
Stem Cells and Development|December 18, 2014
The cerebrospinal fluid-stem cell interactions as target for regenerative therapy in neurological diseasesSriram Durvasula, Jaime Imitola
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Neural stem cells and the future treatment of neurological diseases: raising the standardJaime Imitola, Samia J Khoury
JAMA Neurology|June 14, 2016
Cortical Volume Loss and Neurologic Dysfunction in Multiple SclerosisMichael K Racke, Jaime Imitola
JAMA Neurology|February 28, 2017
Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell TransplantationMichael K Racke, Jaime Imitola
Stem Cell Reports|September 10, 2025
Perturbing neural stem cell fate in glioblastoma heterogeneity and beyondEthan W Hollingsworth, Jaime Imitola
JAMA Neurology|December 23, 2014
Is no evidence of disease activity a realistic goal for patients with multiple sclerosis?Jaime Imitola, Michael K Racke
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Journal of Neuroimmunology|April 27, 2019
Regenerative neuroimmunology: The impact of immune and neural stem cell interactions for translation in neurodegeneration and repairJaime Imitola
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2019
New age for progressive multiple sclerosisJaime Imitola
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 9, 2007
Prospects for neural stem cell-based therapies for neurological diseasesJaime Imitola
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2022
All anti-CD20 monoclonal antibodies have similar efficacy and risks: CommentaryIan Dimaandal, Jaime Imitola
Stem Cells and Development|December 18, 2014
The cerebrospinal fluid-stem cell interactions as target for regenerative therapy in neurological diseasesSriram Durvasula, Jaime Imitola
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Neural stem cells and the future treatment of neurological diseases: raising the standardJaime Imitola, Samia J Khoury
JAMA Neurology|June 14, 2016
Cortical Volume Loss and Neurologic Dysfunction in Multiple SclerosisMichael K Racke, Jaime Imitola
JAMA Neurology|February 28, 2017
Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell TransplantationMichael K Racke, Jaime Imitola
Stem Cell Reports|September 10, 2025
Perturbing neural stem cell fate in glioblastoma heterogeneity and beyondEthan W Hollingsworth, Jaime Imitola
JAMA Neurology|December 23, 2014
Is no evidence of disease activity a realistic goal for patients with multiple sclerosis?Jaime Imitola, Michael K Racke
Pageof 10